Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Intercardia and Knoll reach agreement for CHF drug

Dec. 24, 1996

Genzyme commences cardiovascular gene therapy collaboration

Dec. 20, 1996

Dual NEP/ACE inhibitors claimed by Eisai

Dec. 20, 1996

Therapeutically active nicotinic acid esters described by Scotia

Dec. 19, 1996

Biovail grants another license for diltiazem product

Dec. 18, 1996

Beta-blocker treatment reduces fatal post-surgical heart attack

Dec. 18, 1996

Method for treatment of CPVD available for licensing

Dec. 17, 1996

New ET-1 inhibitors from Ciba-Geigy

Dec. 16, 1996

Toray reports peptides for toxic shock syndrome

Dec. 16, 1996

New antihypertensive agents from Banyu

Dec. 16, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...